tm
Seeing Is Believing
tm
Seeing Is Believing
NAUT is currently covered by 2 analysts with an average price target of $2.35. This is a potential upside of $1.35 (135%) from yesterday's end of day stock price of $1.
Nautilus Biotechnology's activity chart (see below) currently has 9 price targets and 9 ratings on display. The stock rating distribution of NAUT is 66.67% HOLD and 33.33% SELL.
Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 55.5 days.
Highest price target for NAUT is $1.75, Lowest price target is $1.75, average price target is $3.88.
Most recent stock forecast was given by MATTHEW SYKES from GOLDMAN SACHS on 05-Dec-2024. First documented stock forecast 04-Aug-2021.
Currently out of the existing stock ratings of NAUT, 2 are a HOLD (66.67%), 1 are a SELL (33.33%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
$1.75
$0.64 (57.66%)
$3
3 months 16 days ago
(05-Dec-2024)
4/6 (66.67%)
$-0.17 (-8.85%)
111
Hold
$6
$4.89 (440.54%)
$6
1 years 7 months 18 days ago
(03-Aug-2023)
0/2 (0%)
$2.86 (91.08%)
What is NAUT (Nautilus Biotechnology) average time for price targets to be met?
Which analyst has the current highest performing score on NAUT (Nautilus Biotechnology) with a proven track record?
Which analyst has the current lower performing score on NAUT (Nautilus Biotechnology) with a proven track record?
Which analyst has the most public recommendations on NAUT (Nautilus Biotechnology)?
Which analyst is the currently most bullish on NAUT (Nautilus Biotechnology)?
Which analyst is the currently most reserved on NAUT (Nautilus Biotechnology)?
